Drug launch timing and international reference pricing

Nicolas Houy and Izabela Jelovac

Post-Print from HAL

Abstract: This paper analyzes the timing decisions of pharmaceutical firms to launch a new drug in countries involved in international reference pricing. We show three important features of launch timing when all countries refer to the prices in all other countries and in all previous periods of time. First, there is no withdrawal of drugs in any country and in any period. Second, whenever the drug is sold in a country, it is also sold in all countries with larger willingness to pay. Third, there is no strict incentive to delay the launch of a drug in any country. We then show that the first and third results continue to hold when the countries only refer to the prices of a subset of all countries in a transitive way and in any period. We also show that the second result continues to hold when the reference is on the last period prices only. Last, we show that the seller's profits increase as the sets of reference countries decrease with respect to inclusion.

Keywords: Drug launch timing; international reference pricing (search for similar items in EconPapers)
Date: 2014-07-07
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-00993816v1
References: View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Published in Health Economics, 2014, 24 (8), pp.978-989. ⟨10.1002/hec.3078⟩

Downloads: (external link)
https://shs.hal.science/halshs-00993816v1/document (application/pdf)

Related works:
Journal Article: Drug Launch Timing and International Reference Pricing (2015)
Working Paper: Drug launch timing and international reference pricing (2014)
Working Paper: Drug launch timing and international reference pricing (2014)
Working Paper: Drug launch timing and international reference pricing (2013)
Working Paper: Drug launch timing and international reference pricing (2013)
Working Paper: Drug launch timing and international reference pricing (2013)
Working Paper: Drug launch timing and international reference pricing (2013)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-00993816

DOI: 10.1002/hec.3078

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().